Bio-Rad Laboratories (BIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
| Sales | 2,132,694 | 2,069,235 | 2,073,529 | 1,927,118 | 1,784,244 |
| Cost of Goods | 954,216 | 914,077 | 894,700 | 835,630 | 784,401 |
| Gross Profit | 1,178,478 | 1,155,158 | 1,178,829 | 1,091,488 | 999,843 |
| Operating Expenses | 1,009,238 | 891,059 | 874,288 | 808,109 | 769,256 |
| Operating Income | 169,456 | 264,176 | 305,241 | 284,009 | 230,988 |
| Interest Expense | 61,271 | 51,112 | 53,135 | 63,717 | 47,024 |
| Other Income | 4,200 | 16,843 | -6,259 | -9 | 1,868 |
| Pre-tax Income | 112,385 | 229,907 | 245,847 | 220,283 | 185,832 |
| Income Tax | 34,574 | 64,361 | 67,034 | 33,348 | 36,667 |
| Net Income Continuous | 77,811 | 165,546 | 178,813 | 186,935 | 149,165 |
| Minority Interests | 21 | 69 | -200 | 1,445 | 4,545 |
| Net Income | $77,790 | $165,477 | $179,013 | $185,490 | $144,620 |
| EPS Basic Total Ops | 2.72 | 5.85 | 6.39 | 6.70 | 5.28 |
| EPS Basic Continuous Ops | 2.72 | 5.85 | 6.38 | 6.76 | 5.44 |
| EPS Diluted Total Ops | 2.69 | 5.78 | 6.29 | 6.59 | 5.20 |
| EPS Diluted Continuous Ops | 2.69 | 5.78 | 6.28 | 6.64 | 5.36 |
| EBITDA(a) | $169,456 | $264,176 | $305,241 | $284,009 | $230,988 |